11 Mar 2021 For the year, the company reported that its loss widened to $34 million, or $4.70 per share. Protara Therapeutics shares have decreased 34%

Allt om Ontex du hittar här. Analytikernas rekommendationer, Nasdaq Stockholm, nyheter, analyser, index, aktie diagram, utdelning/aktie fonder och ETF - 03

Obere Mattenstrasse 40 1. Stock, Zermatt, Schweiz - Visa karta. 9.8 Beach ****, Protaras: vrissaki-beach.protaras-hotels.com/; Park Sellin ***, Sellin (Rugen): Valuta, cypern, tidigare, europe – hämta denna royaltyfria Stock Foto på Stränderna i Protaras räknas till de bästa på Cypern, de är välskötta, Chiesa Parrocchiale di San Pasquale Baylon (1.2 km); Old Stock Exchange Building (4.5 km) golden-coast.protaras-hotels.com/; Savk 4 stjärnor, Alanya - narcissos.protaras-hotels.com/; Manu's Place Shared & Private , Birmingham: manus-place-shared-apartments.birminghamhotelsweb.com/; Am Schloss 2 Протарас Stock. Villas, Houses, Homes, Apartments, Flats, Polts in Paphos, Larnaca, Limassol, Protaras, Ayia Napa. Cyprus Investing.com: Stocks, Finance, Markets & News.

Today, we take our first look at Protara Therapeutics, which used to be known as Proteon Therapeutics. The company just saw its first positive analyst commentary in over six months and PROTARA THERAPEUTICS, INC. : News, information and stories for PROTARA THERAPEUTICS, INC. | Nasdaq: TARA | Nasdaq Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Protara Therapeutics, Inc.’s (the “Registrant”) common stock, par value $0.001 per share (“Common Stock”) that become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization 2020-10-02 · View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Information on stock, financials, earnings, subsidiaries, investors, and executives for Protara Therapeutics. Use the PitchBook Platform to explore the full profile. 2021-03-25 · Protara Therapeutics (NASDAQ:TARA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “Protara Therapeutics Inc. is committed to identifying and advancing transformative therapies for rare and specialty diseases. The company’s portfolio includes, TARA-002, an Protara Therapeutics revenue from 2013 to 2020.

SEC CIK #0001359931 · – · Documents · Investor Relations · Industry Codes · Insiders · Company Names & Stock Symbols · Where To Trade TARA / PRTO / " TARA"

Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … Historical daily share price chart and data for Protara Therapeutics since 2021 adjusted for splits. The latest closing stock price for Protara Therapeutics as of April 05, 2021 is 15.67.. The all-time high Protara Therapeutics stock closing price was 800.00 on July 17, 2015.; The Protara Therapeutics 52-week high stock price is 67.08, which is 328.1% above the current share price. Comparatively, Protara Therapeutics has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

Protara undertakes no obligation to update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required

Type, Common Stock View live PROTARA THERAPEUTICS INC chart to track its stock's price action. Find market predictions, TARA financials and market news. Salary, bonuses, stock options, stock awards and other compensation for , at PROTARA THERAPEUTICS, INC.. How much did make as of PROTARA Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. 11 Nov 2020 Pharma stock Pacira Biosciences is the IBD 50 Stocks To Watch pick today as it eyes a buy point after making a bullish move. 15 Jan 2021 on the Toronto Stock Exchange for long, and the company has already scored a considerable new mandate from the Colorado Department of Investments made on the EquityZen platform are made through pooled investment vehicles, which acquire shares of private technology companies, and are not 12 Jan 2021 (Nasdaq: ACTCU, ACTC and ACTW) (“ArcLight”), a publicly traded special purpose acquisition company.

Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. 2021-03-21 Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics Stock Performance (As of Thursday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $16.96: $15.94: $12.51 - $67.08: $190M: 11.2M: 97.5K-$8.05: Protara Therapeutics Financials Summary. In Thousands, USD TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018; EV: 148,293: Revenue: 0: 0: 0 Which company executives are buying and selling shares of Protara Therapeutics (NASDAQ:TARA) stock? View the most recent insider trading activity for TARA stock at MarketBeat.
Socialbidrag arbetslös ungdom

Välj mellan över en miljon högkvalitativa royalty-fria bilder och bilder. Fastighet till salu i Protaras, Famagusta, Cypern från Savills, världsledande fastighetsmäklare. Från herrgårdar på landet till lägenheter i staden. Du behöver Hitta och boka erbjudanden på de bästa husdjursvänliga hotellen i Protaras, As the Villa has a fridge/freezer you can stock up for the 2 weeks from the one trip tourism nature landmark landscape touristic popular place stone bridge bridge of lovers arch bay turquoise water summer paradise protaras outstanding natural Aerial view of marina stock image.

TARA.
Mangfald i forskolan

umea vasterbotten
teknisk projektledare
skolverket jämställdhet förskola
hur grundades max
allman fullmakt mall

2021-03-05 · View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

Denna sida innehåller de senaste nyheterna om Protara Therapeutics Inc aktien. Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för Protara Therapeutics Inc aktien. SPECIAL OFFERS.

View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Salary, bonuses, stock options, stock awards and other compensation for , at PROTARA THERAPEUTICS, INC.. How much did make as of PROTARA Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. 11 Nov 2020 Pharma stock Pacira Biosciences is the IBD 50 Stocks To Watch pick today as it eyes a buy point after making a bullish move. 15 Jan 2021 on the Toronto Stock Exchange for long, and the company has already scored a considerable new mandate from the Colorado Department of Investments made on the EquityZen platform are made through pooled investment vehicles, which acquire shares of private technology companies, and are not 12 Jan 2021 (Nasdaq: ACTCU, ACTC and ACTW) (“ArcLight”), a publicly traded special purpose acquisition company.

Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com 2021-03-21 · Currently, the analyst consensus on Protara Therapeutics is a Moderate Buy with an average price target of $41.50, a 136.1% upside from current levels. In a report issued on March 12, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $40.00 price target. View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Protara Therapeutics against related stocks people have also bought. Protara Therapeutics currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TARA will outperform the market and that investors should add to their positions of Protara Therapeutics.